Jun Shimizu
Impact in
- Immunology top 0.05%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immune cells in cancer
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 42
- T-cell and B-cell Immunology 31
- Immune Cell Function and Interaction 31
- Immunotherapy and Immune Responses 27
-
- Cardiac Valve Diseases and Treatments 22
- Co-authors
- Shimon Sakaguchi (12 shared papers)Sayuri Yamazaki (8 shared papers)Takeshi Takahashi (5 shared papers)Noriko Sakaguchi (5 shared papers)Yuhshi Kuniyasu (5 shared papers)Takashi Nomura (4 shared papers)Misako Itoh (4 shared papers)Shimon Sakaguchi (3 shared papers)
- Journals
- The Journal of Immunology (17 papers)Cardiovascular Intervention and Therapeutics (5 papers)Bulletin of the Chemical Society of Japan (4 papers)The Journal of Experimental Medicine (3 papers)Cancer Immunology Immunotherapy (3 papers)
- Partner nations
- JapanUnited StatesThailand
In The Last Decade
Jun Shimizu
135 papers receiving 12.8k citations
Jun Shimizu's Hit Papers
Peers
Comparison fields: 5 of 134
- Immunology 9.8k
- Oncology 2.7k
- Transplantation 172
- Genetics 1.0k
- Hematology 387
Countries citing papers authored by Jun Shimizu
This map shows the geographic impact of Jun Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Shimizu more than expected).
Fields of papers citing papers by Jun Shimizu
This network shows the impact of papers produced by Jun Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Shimizu. The network helps show where Jun Shimizu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Shimizu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 Hit paper breakdown → | 2000 | 1805 |
| 2 | Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance Hit paper breakdown → | 2002 | 1414 |
| 3 | Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease Hit paper breakdown → | 2006 | 1272 |
| 4 | Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Hit paper breakdown → | 1998 | 1272 |
| 5 | Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Hit paper breakdown → | 2001 | 1233 |
| 6 | Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity Hit paper breakdown → | 1999 | 1214 |
| 7 | Thymus and Autoimmunity: Production of CD25+CD4+ Naturally Anergic and Suppressive T Cells as a Key Function of the Thymus in Maintaining Immunologic Self-Tolerance Hit paper breakdown → | 1999 | 995 |
| 8 | Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Hit paper breakdown → | 1999 | 887 |
| 9 | Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3 + CD25 + CD4 + regulatory T cells Hit paper breakdown → | 2005 | 409 |
| 10 | 2000 | 238 | |
| 11 | 2012 | 201 | |
| 12 | 1996 | 188 | |
| 13 | 2006 | 179 | |
| 14 | 1993 | 134 | |
| 15 | 2006 | 133 | |
| 16 | 2015 | 94 | |
| 17 | 1982 | 77 | |
| 18 | 1988 | 76 | |
| 19 | 1993 | 65 | |
| 20 | Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. | 1988 | 64 |
About Jun Shimizu
Jun Shimizu is a scholar working on Immunology, Cardiology and Cardiovascular Medicine, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 145 papers that have together received 13.0k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (31 papers), Immune Cell Function and Interaction (31 papers), Immunotherapy and Immune Responses (27 papers), Cardiac Valve Diseases and Treatments (22 papers), Diabetes and associated disorders (9 papers), Infective Endocarditis Diagnosis and Management (9 papers), Aortic Disease and Treatment Approaches (7 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Immunology (9.8k citations), Oncology (2.7k citations), Transplantation (172 citations), Genetics (1.0k citations) and Hematology (387 citations). Jun Shimizu has collaborated with scholars based in Japan, United States and Thailand. Frequent co-authors include Shimon Sakaguchi, Sayuri Yamazaki, Takeshi Takahashi, Noriko Sakaguchi, Yuhshi Kuniyasu, Takashi Nomura, Misako Itoh, Shimon Sakaguchi, Yasumasa Ishida and Toshimitsu Uede. Their work appears in journals such as The Journal of Immunology, Cardiovascular Intervention and Therapeutics, Bulletin of the Chemical Society of Japan, The Journal of Experimental Medicine and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.